Global Alcohol Free Disinfectant Wipes Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030Alcohol Free Disinfectant Wipes, use non-woven fabrics, fabrics, dust-free paper or other raw materials as the carrier, purified water as production water, appropriate addition of raw materials such as disinfectant (Without alcohol), etc., which has a cleaning and disinfecting effect on the human body, general object surfaces, medical device surfaces and other object surfaces product. The Alcohol Free Disinfectant Wipes industry can be broken down into several segments, Quaternary Ammonium Compounds, Chlorine-based, etc. The global Alcohol Free Disinfectant Wipes market size was valued at US$ 1897 million in 2023 and is forecast to a readjusted size of USD 2868 million by 2030 with a CAGR of 6.2% during review period. Currently, many players such as The Clorox Company, GAMA Healthcare, Diversey as well as some others are playing important roles in Alcohol Free Disinfectant Wipes industry. There are many different types of Alcohol Free Disinfectant Wipes. The...Read more | USD 3,480.00 |
Global Tuberculosis (TB) Detection Market 2024 by Company, Regions, Type and Application, Forecast to 2030Tuberculosis (TB) is a chronic infection caused by the bacterium tuberculosis (TB).Tuberculous bacterium invades human body all sorts of organs possibly, but basically encroach lung, call tuberculosis disease. Tuberculosis (TB) is a chronic and slow - onset infectious disease in young people.The incubation period is 4 to 8 weeks.Of these, 80% occur in the lungs, and other areas (cervical lymph, meninges, peritoneum, intestine, skin, bone) may also be secondary to infection.Transmission of respiratory tract from person to person is the main mode of transmission.Infection source is the person that contacts the tuberculosis that discharges bacterium.With the spread of environmental pollution and AIDS, the incidence of TB is becoming more and more intense.In addition to a few cases of rapid onset, clinical more chronic process.There are often low fever, fatigue and other systemic symptoms and respiratory symptoms such as cough, hemoptysis. The global Tuberculosis (TB)...Read more | USD 3,480.00 |
Global Normal Saline for Parenteral Use Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030Normal saline is a mixture of salt and water. It is called normal because its salt concentration is similar to tears, blood and other body fluids (0.9% saline). It is also called isotonic solution. It has a number of uses in medicine. By injection into a vein it is used to treat dehydration such as from gastroenteritis and diabetic ketoacidosis. It is also used to dilute other medications to be given by injection. This report studies Normal Saline for Parenteral Use market in hospital and clinics, and usually refers to Sodium Chloride Injection The global Normal Saline for Parenteral Use market size was valued at US$ 3338 million in 2023 and is forecast to a readjusted size of USD 4130 million by 2030 with a CAGR of 3.1% during review period. At present, Baxter, Kelun Group, B. Braun, Fresenius Kabi and SSY Group are the top five manufacturers of gastrointestinal saline in the world, with a total market share of more than 45%.They are also the world"s largest...Read more | USD 3,480.00 |
Global Fish Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030Fish vaccine are vaccine specially used on fish. The culture environment, be it in tanks, cages or ponds, seawater or freshwater, can stress the fish due to high stocking densities, reduced oxygen levels, sub-optimal water quality and high pathogen loads. Therefore, farmed fish, similar to farmed animals, have an increased susceptibility to infectious diseases. Such diseases may be bacterial, viral, fungal or parasitic in origin. These are the immune foundations for immunizing fish against various diseases. The global Fish Vaccine market size was valued at US$ 383 million in 2023 and is forecast to a readjusted size of USD 695 million by 2030 with a CAGR of 9.0% during review period. The industry"s leading producers are Zoetis and Merck & Co., Inc., which accounted for 52.92% and 34.85% of revenue in 2019, respectively. This report is a detailed and comprehensive analysis for global Fish Vaccine market. Both quantitative and qualitative analyses are...Read more | USD 3,480.00 |
Global Dengue Vaccines Market 2024 by Company, Regions, Type and Application, Forecast to 2030Dengue vaccine is a vaccine used to prevent dengue fever in humans. As of 2019, one version is commercially available, known as CYD-TDV, and sold under the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected. The value of the vaccine is limited by the fact that it may worsen outcomes in those who have not previously been infected. It is given as three injections over a year. The global Dengue Vaccines market size was valued at US$ 477 million in 2023 and is forecast to a readjusted size of USD 1179 million by 2030 with a CAGR of 14.0% during review period. The only one version which is commercially available now, known as Dengvaxia and produced by Sanofi, don't has enough efficacy. While there are several vaccines are on trial now. TAK-003, developed by Takeda is one stride closer to reaching the sizable market waiting for dengue vaccines as it reports...Read more | USD 3,480.00 |